S&P 500
(0.11%) 5 254.35 points
Dow J
(0.12%) 39 807 points
Nasdaq
(-0.12%) 16 379 points
Oil
(2.05%) $83.02
Gas
(1.63%) $1.746
Gold
(1.30%) $2 241.40
Silver
(0.97%) $24.99
Platinum
(1.32%) $921.75
USD/EUR
(0.39%) $0.927
USD/NOK
(0.80%) $10.85
USD/GBP
(0.13%) $0.792
USD/RUB
(0.13%) $92.56

Realtime updates for VYNE Therapeutics Inc. [VYNE]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated28 Mar 2024 @ 16:00

3.72% $ 3.07

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 16:00):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, which is in Phase IIa preclinical trial for the treatment of mild-to-moderate atopic dermatitis...

Stats
Today's Volume 283 020
Average Volume 125 355
Market Cap 43.28M
EPS $0 ( 2024-03-14 )
Next earnings date ( $-0.240 ) 2024-05-09
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -1.130
ATR14 $0.0230 (0.75%)
Insider Trading
Date Person Action Amount type
2024-01-01 Zeronda Tyler Buy 62 500 Common Stock
2024-01-02 Zeronda Tyler Sell 93 Common Stock
2024-01-01 Zeronda Tyler Buy 62 500 Stock Option (right to buy)
2024-01-01 Stuart Iain Buy 62 500 Common Stock
2024-01-02 Stuart Iain Sell 157 Common Stock
INSIDER POWER
-56.54
Last 99 transactions
Buy: 3 356 313 | Sell: 7 912 153

Volume Correlation

Long: -0.14 (neutral)
Short: 0.23 (neutral)
Signal:(55.033) Neutral

VYNE Therapeutics Inc. Correlation

10 Most Positive Correlations
ALBO0.962
CMPI0.962
OCSL0.934
PALT0.913
IRMD0.911
PLRX0.91
MLAC0.905
ANDE0.905
NATI0.903
DRNA0.902
10 Most Negative Correlations
CFV-0.951
AKAM-0.888
BNIXU-0.882
GMII-0.88
TUEM-0.874
EAR-0.85
SHLD-0.845
TRMK-0.84
DTSS-0.838
VIVE-0.837

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

VYNE Therapeutics Inc. Correlation - Currency/Commodity

The country flag 0.09
( neutral )
The country flag -0.13
( neutral )
The country flag 0.00
( neutral )
The country flag -0.47
( neutral )
The country flag 0.58
( weak )
The country flag -0.41
( neutral )

VYNE Therapeutics Inc. Financials

Annual 2023
Revenue: $424 000
Gross Profit: $424 000 (100.00 %)
EPS: $-2.77
Q4 2023
Revenue: $76 000.00
Gross Profit: $76 000.00 (100.00 %)
EPS: $-0.200
Q3 2023
Revenue: $114 000
Gross Profit: $114 000 (100.00 %)
EPS: $-2.01
Q2 2023
Revenue: $135 000
Gross Profit: $135 000 (100.00 %)
EPS: $-3.07

Financial Reports:

No articles found.

VYNE Therapeutics Inc.

VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, which is in Phase IIa preclinical trial for the treatment of mild-to-moderate atopic dermatitis. It is also developing VYN201, a bromodomain and extra-terminal (BET) inhibitor for various immuno-inflammatory diseases, including skin diseases; and VYN202, BET inhibitor compounds that are selective for bromodomain 2. The company was formerly known as Menlo Therapeutics Inc. and changed its name to VYNE Therapeutics Inc. in September 2020. VYNE Therapeutics Inc. was founded in 2003 and is based in Bridgewater, New Jersey.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators